Cart
sales@molnova.com
2,6-Dibromophenol
CAS No. 608-33-3
2,6-Dibromophenol( 2,6-Dibromo-phenol )
Catalog No. M28154 CAS No. 608-33-3
2,6-Dibromophenol is extracted from the skin and muscle of flatfish.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 28 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | 27 | In Stock |
|
Biological Information
-
Product Name2,6-Dibromophenol
-
NoteResearch use only, not for human use.
-
Brief Description2,6-Dibromophenol is extracted from the skin and muscle of flatfish.
-
Description2,6-Dibromophenol is extracted from the skin and muscle of flatfish.
-
In Vitro——
-
In Vivo——
-
Synonyms2,6-Dibromo-phenol
-
PathwayProteasome/Ubiquitin
-
TargetEndogenous Metabolite
-
RecptorNK3
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number608-33-3
-
Formula Weight251.9
-
Molecular FormulaC6H4Br2O
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (396.98 mM)
-
SMILESBrC1=CC=CC(Br)=C1O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Medhurst AD, et, al. In vitro and in vivo characterization of NK3 receptors in the rabbit eye by use of selective non-peptide NK3 receptor antagonists. Br J Pharmacol. 1997 Oct;122(3):469-76.
molnova catalog
related products
-
D-(+)-Turanose
D(+)-Turanose is a naturally occuring compound. It is a reducing disaccharide.
-
5'-DEOXYADENOSINE
5'-Deoxyadenosine is an oxidized nucleoside found in the urine of normal subjects. Oxidized nucleosides represent excellent biomarkers for determining the extent of damage in genetic material which has long been of interest in understanding the mechanism of aging neurodegenerative diseases and carcinogenesis.
-
1-Methylguanosine
1-Methylguanosine is a methylated nucleoside. It is known that some modified, especially methylated, nucleosides originating from RNA degradation are excreted in abnormal levels in the urine of patients with malignant tumors.
